You are currently viewing a new version of our website. To view the old version click .
MDPIMDPI
Search all articles
Journal: PharmaceuticalsVolume: 18Number: 1355
Article: Correction: Hou et al. S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer. Pharmaceuticals 2023, 16, 749
  • Authors:
  • Zhenyan Hou1,
  • Songwen Lin1,2 and
  • Tingting Du1
  • et al.
Link: https://www.mdpi.com/1424-8247/18/9/1355

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Production Quality: High quality (printed in full color on glossy, 135g/m2 paper and 2x stitched)

Shipping Address

Billing Address

0 / 500
The order must be prepaid after it is placed.